Industry Developments

BMI View: Though Jordan's pharmaceutical exports were poor in 2011, they should return to growth in 2012 as stability returns to the region and loose fiscal policy drives government... 2012-03-02

BMI View: While we acknowledge the efforts made by the Pharmaceutical Research and Manufacturers of America (PhRMA) to ensure the best possible operating environment for their members... 2012-03-01

BMI View: In line with BMI's view that public healthcare spending in Saudi Arabia would be greatly boosted by government initiatives in 2012 there has been a flurry of activity in the... 2012-02-28

BMI View: Governments in emerging markets will become increasingly involved in the regulation of pharmaceutical prices, especially in markets where the state accounts for a large percentage... 2012-02-28

BMI Core View: Offshoring manufacturing to low-cost bases will become increasingly prevalent. Multinational drugmakers are looking to cut costs as the effects of the patent cliff take... 2012-02-27

BMI View: Though progress has been made in fighting the prevalence of counterfeit drugs in Nigeria, more could be done from a legislative point of view such as introducing harsher penalties... 2012-02-23

BMI View: The problems within the National Health Insurance System (NHIS) are typical of the Nigerian business environment. Corruption is endemic and the failure of civil servants across... 2012-02-20

BMI View: Following widespread protests in mid-2011, the Israeli government has been under significant pressure to spend more on housing, healthcare and education. While it was not... 2012-02-17

BMI View: The government of South Africa has announced that it has finalised a deal with Swiss pharmaceutical company Lonza to build an active pharmaceutical ingredients (API) manufacturing... 2012-02-17

BMI View: Teva Pharmaceutical Industries continued its lacklustre performance in the last quarter of 2011. Its results showed that very little had improved from BMI's and the market's... 2012-02-16